Teva ceo

Teva share price struggles to recover following $6 billion market loss

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.

 Pills on health form
 Teva building in Kfar Saba

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

 The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019.

Israel's Teva Pharm to start paying US opioid settlement in 2023, says CEO

The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019

Teva's new migraine drug helps contain profit fall


A tribute to companies whose products have become Israeli icons worldwide

ZIM​ CEO Eli Glickman pays homage to the CEOs of Teva Israel, Mehadrin, Keter Plastic, and other prominent Israeli companies

ZIM CEO Eli Glickman, to Teva Israel CEO Avinoam Sapir

Netanyahu thanks United States for 'defending Israel's truth'

Prime Minister Benjamin Netanyahu said that American Vice President Pence is “a great friend of Israel and a great friend of Jerusalem.”

Israeli Prime Minister Benjamin Netanyahu attends the weekly cabinet meeting at the Prime Minister's office in Jerusalem.

Nation girds for general strike today in protest of Teva layoffs

Morning flights halted at Ben-Gurion, public transit to operate as usual.

People protest outside the Teva Pharmaceutical Industries plant in Jerusalem December 14, 2017.

Politicians can decry Teva layoffs, but why did they give billions in tax breaks?

Teva has benefited from an estimated NIS 22 billion ($6.2b.) in tax breaks and subsidies from 2006 until today.

People protest outside the Teva Pharmaceutical Industries plant in Jerusalem December 14, 2017.

Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel

Teva's shares rallied on Thursday in response to the proposed cutbacks, rising more than 15% in one day on the Tel Aviv stock exchange, as of 4pm Israel time.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Teva Pharmaceuticals considers laying-off 10,000 workers

The Petah Tikva-based company seeks to reduce its expenses by $1.5 billion to $2 billion in the next two years.

A building in Jerusalem belonging to generic drug producer Teva

Saving Teva

Why the pharmaceutical giant needs to be bailed out

A building in Jerusalem belonging to generic drug producer Teva

Teva shares plunge again after weak third-quarter

Stock price at lowest level since 2000

A building in Jerusalem belonging to generic drug producer Teva

Yaron Neudorfer, CEO of Social Finance Israel, pays for success

Social Finance Israel, led by Yaron Neudorfer and his team, has dipped its toe into the water.

Yaron Neudorfer

Teva reduces projected layoffs

Once dominant Israeli drug company Teva Pharmaceuticals continues to be battered.

A building in Jerusalem belonging to generic drug producer Teva

Pharmaceutical giant Teva to lay off employees at Israel branches

Israeli media assesses that at some 300 employees would lose their jobs.

Teva Pharmaceutical Industries building in Jerusalem.